Across TCGA pan-cancer cohorts, USP9YP12 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated USP9YP12 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher USP9YP12 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP12 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

UCEC, STAD, and ESCA are the cancer types where USP9YP12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.077	0.679	<.001	126	view →
STAD	OS	Tertile	All	0.142	0.730	<.001	45	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.291	.036	24	view →
SARC	DFS	Tertile	All	0.168	0.612	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: USP9YP12 tumor-vs-normal RNA expression · all USP9YP12 data types